This information is not medical advice and is not a substitute for diagnosis or treatment by a physician.Data sources and disclaimers (data limitations, copyright, etc.)The analysis on "Side Effects of sulfadiazine: A Synthesis of Findings from 29 Studies" on this page is based on PubMed data provided by the U.S. National Library of Medicine (NLM). However, NLM does not endorse or verify these analyses.

This analysis is based on research papers included in PubMed, but medical research is constantly evolving and may not fully reflect the latest findings. There may also be biases towards certain research areas.

This information is not medical advice and is not a substitute for diagnosis or treatment by a physician. If you have concerns about "Side Effects of sulfadiazine: A Synthesis of Findings from 29 Studies", please consult your doctor.

For NLM copyright information, please see Link to NLM Copyright Page
PubMed data is obtained via Hugging Face Datasets: Link to Dataset
Please check the disclaimer.
This page's analysis is based on PubMed data provided by the U.S. National Library of Medicine (NLM).
Original Abstract of the Article

Main Research Findings

Sulfadiazine is a commonly prescribed antibiotic used to treat various bacterial infections. 28 However, research suggests that while sulfadiazine can be effective, it can also have some side effects. 15 29 2 11 21 17 3 14 26 5 12 6 7 16 10 13 One study found that sulfadiazine could cause skin irritation when used to treat burn wounds. 28

Furthermore, sulfadiazine is also used for the treatment of toxoplasmosis, a parasitic infection. 24 While it has shown promise in treating toxoplasmosis, it's essential to be aware of its potential side effects, which can include bone marrow suppression, allergic reactions, liver dysfunction, and kidney dysfunction. 15 29 2 11 21 17 3 14 26 5 12 6 7 16 10

Sulfadiazine is also used to treat HIV infection. 22 11 In this context, research has shown that sulfadiazine can lead to the formation of kidney stones. 22 11

Reason for Side Effects

Sulfadiazine works by inhibiting the growth of bacteria. This occurs because sulfadiazine blocks enzymes that are crucial for bacterial metabolism. However, sulfadiazine may also have adverse effects on human cells due to its potential to inhibit enzymes essential for human cell metabolism.

Common Side Effects

Skin Irritation

Sulfadiazine can cause skin irritation, especially when applied directly to the skin. 28 13

Allergic Reactions

Sulfadiazine can trigger allergic reactions. This side effect is more likely to occur after sulfadiazine has been absorbed into the body. 21 3 10

Bone Marrow Suppression

Sulfadiazine can lead to bone marrow suppression by inhibiting the bone marrow cells. This can increase the risk of infections. 15 29 2 11 6 14

Liver Dysfunction

Sulfadiazine can cause liver dysfunction by inhibiting liver cells. Liver dysfunction may manifest as symptoms like jaundice or hepatitis. 15 10

Kidney Dysfunction

Sulfadiazine can lead to kidney dysfunction by inhibiting kidney cells. Kidney dysfunction can cause symptoms like reduced urine output or swelling. 15 11 10

Kidney Stones

Sulfadiazine can cause kidney stones due to its potential to accumulate in the kidneys and form stones. 22 11

Countermeasures for Side Effects

Countermeasures for Skin Irritation

When applying sulfadiazine to the skin, it is crucial to apply it thinly to minimize irritation. It is also essential to maintain the affected area clean before applying sulfadiazine.

Countermeasures for Allergic Reactions

Inform your doctor about any allergies you may have before taking sulfadiazine. If an allergic reaction occurs, seek immediate medical attention.

Countermeasures for Bone Marrow Suppression

While taking sulfadiazine, regular blood tests are necessary to monitor your bone marrow health. If you experience symptoms of bone marrow suppression, seek immediate medical advice.

Countermeasures for Liver Dysfunction

Regular liver function tests are crucial while taking sulfadiazine to monitor your liver's health. If you experience symptoms of liver dysfunction, seek immediate medical advice.

Countermeasures for Kidney Dysfunction

Regular kidney function tests are necessary while taking sulfadiazine to monitor your kidney health. If you experience symptoms of kidney dysfunction, seek immediate medical advice.

Countermeasures for Kidney Stones

Staying well-hydrated by drinking plenty of fluids is important while taking sulfadiazine. This can help prevent the formation of kidney stones.

Comparison Between Studies

Commonalities in Studies

Numerous studies have demonstrated that sulfadiazine can cause side effects. It's also evident that while sulfadiazine can be an effective treatment for infections, it's crucial to acknowledge and consider the potential risks of side effects.

Differences in Studies

Some studies have indicated that sulfadiazine is particularly effective for treating specific types of infections. Additionally, some studies have shown that certain types of side effects are more commonly associated with sulfadiazine use.

Points to Note Regarding Application to Daily Life

While sulfadiazine can be an effective treatment for infections, it's crucial to be aware of the potential risks of side effects. Before taking sulfadiazine, it's essential to consult with your doctor and receive a thorough explanation of the risks associated with its use.

Limitations of Current Research

Research on sulfadiazine is not yet exhaustive. More research, particularly on the long-term effects of sulfadiazine, is needed. Further studies are necessary to comprehensively assess the safety and efficacy of sulfadiazine.

Future Directions for Research

Additional research is needed to thoroughly evaluate the safety and efficacy of sulfadiazine. This research should focus on understanding its long-term effects. The development of new treatments aimed at mitigating the side effects of sulfadiazine is also essential.

Conclusion

Sulfadiazine is an effective drug for treating infections, but it's crucial to be mindful of the potential risks of side effects. When taking sulfadiazine, consult with your doctor and get a clear explanation of the associated risks. Further research is needed to thoroughly assess the safety and efficacy of sulfadiazine.


Keywords
Benefit Keywords
Atovaquone
Atovaquone TE maintenance therapy
Atovaquone antiparasitic effect
Atovaquone effective
Atovaquone effective for TE
Atovaquone effective for maintenance therapy
Atovaquone effective for toxoplasmic encephalitis
Atovaquone effective for toxoplasmosis
Atovaquone efficacy
Atovaquone efficacy for TE
Atovaquone for TE
Atovaquone for maintenance therapy
Atovaquone for toxoplasmic encephalitis
Atovaquone for toxoplasmosis
Atovaquone maintenance therapy
Atovaquone maintenance therapy efficacy
Atovaquone superior for TE
Atovaquone superior to standard therapy
Atovaquone therapeutic efficacy
Atovaquone therapy
Atovaquone toxoplasmosis treatment
Atovaquone treatment
Atovaquone treats toxoplasmosis
Atovaquone well-tolerated
Effective TE treatment
Effective against TE
Effective for TE
Effective for maintenance therapy
Effective for toxoplasmic encephalitis
Effective for toxoplasmosis
Effective maintenance therapy
Effective maintenance therapy for TE
Effective toxoplasmosis treatment
Effective treatment
Effective treatment for TE
Effective treatment for toxoplasmic encephalitis
Effective treatment of toxoplasmic encephalitis
Improved TE
Improved TE treatment
Improved efficacy
Improved maintenance therapy
Improved survival
Improved survival in TE
Improved therapeutic efficacy
Improved treatment efficacy
Less side effects
Maintenance Therapy
Maintenance therapy
Prevent TE relapse
Prevent relapse of TE
Prevention of relapse
Prevents TE relapse
Protection against TE
Reactivated TE
Reactivated TE treatment
Reactivated toxoplasmic encephalitis treatment
Reduce toxoplasmic encephalitis
Reduced TE
Reduced TE relapse
Reduced TE severity
Reduced brain inflammation
Reduced death rate
Reduced inflammation
Reduced inflammatory changes
Reduced parasite numbers
Reduced relapse
Reduced relapse of TE
Reduced relapse rates
Reduced relapses
Reduced side effects
Reduced toxoplasmic encephalitis
Reduced toxoplasmosis
Reduced toxoplasmosis relapse
Superior maintenance therapy
Superior maintenance therapy for TE
Superior to standard maintenance therapy
Superior to standard therapy
TE maintenance therapy
TE prevention
TE relapse prevention
TE treatment
Therapeutic efficacy
Therapeutic efficacy of atovaquone
Toxoplasmic encephalitis
Toxoplasmic encephalitis treatment
Toxoplasmosis treatment
Treatment for toxoplasmic encephalitis
Treatment for toxoplasmosis
Treatment of toxoplasmic encephalitis
Treatment of toxoplasmosis
Treats reactivated TE
Treats toxoplasmic encephalitis
Treats toxoplasmosis
Well tolerated
Well-tolerated
atovaquone for TE treatment
atovaquone for maintenance therapy
effective for TE
superior to standard therapy
3
Alternative treatment
Alternative treatment for parasitic infections
Anti-HIV PI efficacy
Anti-HIV PIs
Anti-HIV protease inhibitor benefit
Anti-HIV protease inhibitor efficacy
Anti-HIV protease inhibitors
Anti-HIV protease inhibitors may be effective against parasites
Atovaquone for TE
CD4+ T-cell count improvement
Control OPIs
Controls infections
Cryptosporidiosis reduction
Cryptosporidiosis risk reduction
Cryptosporidiosis treatment
Effective HAART
Effective treatment for parasitic infections
Enterocytozoon bieneusi disappearance
Enterocytozoon bieneusi reduction
Enterocytozoon bieneusi treatment
HAART
HAART HIV
HAART OPI
HAART OPI reduction
HAART effective
HAART effective against OPI
HAART effective for OPI
HAART effective in suppressing HIV
HAART effectiveness
HAART efficacy
HAART for E. bieneusi
HAART for HIV
HAART for OPI
HAART for OPIs
HAART for cryptosporidiosis
HAART for isosporiasis
HAART for opportunistic infections
HAART for opportunistic parasite infections
HAART improves chronic diarrhea
HAART opportunistic infection reduction
HAART opportunistic infection treatment
HAART parasite control
HAART reduces OPIs
HAART reduces TE
HAART reduces cryptosporidiosis
HAART reduces isosporiasis
HAART reduces opportunistic infections
HAART reduces parasitic infections
HAART reduces visceral leishmaniasis
HAART treatment
HIV PI antiparasitic effect
HIV PIs effective for parasitic infections
HIV PIs for OPIs
HIV Treatment
HIV infection management
HIV infection treatment
HIV protease inhibitor benefits
HIV protease inhibitor use
HIV protease inhibitors against parasites
HIV protease inhibitors for parasitic infections
HIV therapy
HIV treatment
HIV viral load suppression
HIV-PI benefit for parasitic infections
HIV-PI efficacy
HIV-PI for parasites
HIV-PI for parasitic infections
HIV-PI therapy
HIV-PI treatment
HIV-PI use
HIV-PIs
HIV-PIs effective
HIV-PIs effective for OPI
HIV-PIs effective for OPIs
HIV-PIs for parasites
HIV-PIs for parasitic infections
HIV-PIs may treat parasitic infections
HIV-PIs treat parasitic infections
HIV-positive person treatment
HIV-related infection control
Immune reconstitution
Improve CD4+ T-cell count
Improved CD4 count
Improved CD4+ T-cell count
Improved CD4+ count
Improved HIV treatment
Improved T-cell count
Improved cell immunity
Improved chronic diarrhea
Improved chronic diarrhoea
Improved immune function
Improved immune system
Improved immunity
Isosporiasis reduction
Isosporiasis risk reduction
Isosporiasis treatment
Leishmaniasis treatment
New drug development potential
Non-conventional PI benefits
OPI control
OPI reduction
OPI treatment
Opportunistic infection control
Opportunistic infection prevention
Opportunistic infection reduction
Opportunistic infection treatment
Opportunistic infections
Opportunistic infections control
Opportunistic parasite infection control
Opportunistic parasite infection reduction
Opportunistic parasite infections treatment
PI benefits
PI efficacy
PI for parasite control
PI treatment
PIs effective
PIs effective against parasites
PIs inhibit parasite proteases
PIs parasitic
Parasite Control
Parasite control
Parasite infection control
Parasite infection treatment
Parasite protease inhibition
Parasitic infection treatment
Parasitic infections
Possible alternative treatment for parasitic infections
Possible parasite protease inhibition
Potential new drug development
Potential treatment of parasitic infections
Protozoa treatment
Reconstitution of cell immunity
Reconstructed cell immunity
Reduce HIV viral load
Reduce opportunistic infections
Reduced Cryptosporidiosis
Reduced HIV infections
Reduced HIV viral load
Reduced Isosporiasis
Reduced Leishmania
Reduced OPI
Reduced OPI incidence
Reduced OPI risk
Reduced OPIs
Reduced TE
Reduced TE incidence
Reduced TE risk
Reduced cryptosporidiosis
Reduced isosporiasis
Reduced opportunistic infections
Reduced opportunistic parasite infections
Reduced toxoplasmic encephalitis
Reduced toxoplasmosis
Reduced viral load
Reduced visceral leishmaniasis
Reduces HIV viral load
Reduces OPIs
Reduction of OPIs
Reduction of opportunistic infections
Ritonavir and nelfinavir inhibit T. gondii
Stronger cell immunity
Suppressed HIV viral load
Suppression of HIV viral load
TE reduction
Toxoplasmic encephalitis treatment
Treatment for parasitic infections
Treats HIV
Treats opportunistic infections
Treats parasitic infections
Visceral leishmaniasis incidence decrease
Visceral leishmaniasis reduction
chronic diarrhoea improvement
cryptosporidiosis risk reduction
death risk reduction for cryptosporidiosis
isosporiasis relative hazard reduction
opportunistic infection reduction
potential for alternative parasitic treatment
reduced opportunistic infections
toxoplasmic encephalitis reduction
visceral leishmaniasis incidence decrease
6
Risk Keywords
Literature analysis of 29 papers
Positive Content
10
Neutral Content
0
Negative Content
2
Article Type
1
1
0
6
29

Language : English


Language : English


Author: DunayIldiko R, HeimesaatMarkus M, BushrabFaris Nadiem, MüllerRainer H, StockerHartmut, ArastehKeikawus, KurowskiMichael, FitznerRudolf, BornerKlaus, LiesenfeldOliver


Atovaquone
Atovaquone TE maintenance therapy
Atovaquone antiparasitic effect
Atovaquone effective
Atovaquone effective for TE
Atovaquone effective for maintenance therapy
Atovaquone effective for toxoplasmic encephalitis
Atovaquone effective for toxoplasmosis
Atovaquone efficacy
Atovaquone efficacy for TE
Atovaquone for TE
Atovaquone for maintenance therapy
Atovaquone for toxoplasmic encephalitis
Atovaquone for toxoplasmosis
Atovaquone maintenance therapy
Atovaquone maintenance therapy efficacy
Atovaquone superior for TE
Atovaquone superior to standard therapy
Atovaquone therapeutic efficacy
Atovaquone therapy
Atovaquone toxoplasmosis treatment
Atovaquone treatment
Atovaquone treats toxoplasmosis
Atovaquone well-tolerated
Effective TE treatment
Effective against TE
Effective for TE
Effective for maintenance therapy
Effective for toxoplasmic encephalitis
Effective for toxoplasmosis
Effective maintenance therapy
Effective maintenance therapy for TE
Effective toxoplasmosis treatment
Effective treatment
Effective treatment for TE
Effective treatment for toxoplasmic encephalitis
Effective treatment of toxoplasmic encephalitis
Improved TE
Improved TE treatment
Improved efficacy
Improved maintenance therapy
Improved survival
Improved survival in TE
Improved therapeutic efficacy
Improved treatment efficacy
Less side effects
Maintenance Therapy
Maintenance therapy
Prevent TE relapse
Prevent relapse of TE
Prevention of relapse
Prevents TE relapse
Protection against TE
Reactivated TE
Reactivated TE treatment
Reactivated toxoplasmic encephalitis treatment
Reduce toxoplasmic encephalitis
Reduced TE
Reduced TE relapse
Reduced TE severity
Reduced brain inflammation
Reduced death rate
Reduced inflammation
Reduced inflammatory changes
Reduced parasite numbers
Reduced relapse
Reduced relapse of TE
Reduced relapse rates
Reduced relapses
Reduced side effects
Reduced toxoplasmic encephalitis
Reduced toxoplasmosis
Reduced toxoplasmosis relapse
Superior maintenance therapy
Superior maintenance therapy for TE
Superior to standard maintenance therapy
Superior to standard therapy
TE maintenance therapy
TE prevention
TE relapse prevention
TE treatment
Therapeutic efficacy
Therapeutic efficacy of atovaquone
Toxoplasmic encephalitis
Toxoplasmic encephalitis treatment
Toxoplasmosis treatment
Treatment for toxoplasmic encephalitis
Treatment for toxoplasmosis
Treatment of toxoplasmic encephalitis
Treatment of toxoplasmosis
Treats reactivated TE
Treats toxoplasmic encephalitis
Treats toxoplasmosis
Well tolerated
Well-tolerated
atovaquone for TE treatment
atovaquone for maintenance therapy
effective for TE
superior to standard therapy

Language : English


Language : English


Author: PozioE


Alternative treatment
Alternative treatment for parasitic infections
Anti-HIV PI efficacy
Anti-HIV PIs
Anti-HIV protease inhibitor benefit
Anti-HIV protease inhibitor efficacy
Anti-HIV protease inhibitors
Anti-HIV protease inhibitors may be effective against parasites
Atovaquone for TE
CD4+ T-cell count improvement
Control OPIs
Controls infections
Cryptosporidiosis reduction
Cryptosporidiosis risk reduction
Cryptosporidiosis treatment
Effective HAART
Effective treatment for parasitic infections
Enterocytozoon bieneusi disappearance
Enterocytozoon bieneusi reduction
Enterocytozoon bieneusi treatment
HAART
HAART HIV
HAART OPI
HAART OPI reduction
HAART effective
HAART effective against OPI
HAART effective for OPI
HAART effective in suppressing HIV
HAART effectiveness
HAART efficacy
HAART for E. bieneusi
HAART for HIV
HAART for OPI
HAART for OPIs
HAART for cryptosporidiosis
HAART for isosporiasis
HAART for opportunistic infections
HAART for opportunistic parasite infections
HAART improves chronic diarrhea
HAART opportunistic infection reduction
HAART opportunistic infection treatment
HAART parasite control
HAART reduces OPIs
HAART reduces TE
HAART reduces cryptosporidiosis
HAART reduces isosporiasis
HAART reduces opportunistic infections
HAART reduces parasitic infections
HAART reduces visceral leishmaniasis
HAART treatment
HIV PI antiparasitic effect
HIV PIs effective for parasitic infections
HIV PIs for OPIs
HIV Treatment
HIV infection management
HIV infection treatment
HIV protease inhibitor benefits
HIV protease inhibitor use
HIV protease inhibitors against parasites
HIV protease inhibitors for parasitic infections
HIV therapy
HIV treatment
HIV viral load suppression
HIV-PI benefit for parasitic infections
HIV-PI efficacy
HIV-PI for parasites
HIV-PI for parasitic infections
HIV-PI therapy
HIV-PI treatment
HIV-PI use
HIV-PIs
HIV-PIs effective
HIV-PIs effective for OPI
HIV-PIs effective for OPIs
HIV-PIs for parasites
HIV-PIs for parasitic infections
HIV-PIs may treat parasitic infections
HIV-PIs treat parasitic infections
HIV-positive person treatment
HIV-related infection control
Immune reconstitution
Improve CD4+ T-cell count
Improved CD4 count
Improved CD4+ T-cell count
Improved CD4+ count
Improved HIV treatment
Improved T-cell count
Improved cell immunity
Improved chronic diarrhea
Improved chronic diarrhoea
Improved immune function
Improved immune system
Improved immunity
Isosporiasis reduction
Isosporiasis risk reduction
Isosporiasis treatment
Leishmaniasis treatment
New drug development potential
Non-conventional PI benefits
OPI control
OPI reduction
OPI treatment
Opportunistic infection control
Opportunistic infection prevention
Opportunistic infection reduction
Opportunistic infection treatment
Opportunistic infections
Opportunistic infections control
Opportunistic parasite infection control
Opportunistic parasite infection reduction
Opportunistic parasite infections treatment
PI benefits
PI efficacy
PI for parasite control
PI treatment
PIs effective
PIs effective against parasites
PIs inhibit parasite proteases
PIs parasitic
Parasite Control
Parasite control
Parasite infection control
Parasite infection treatment
Parasite protease inhibition
Parasitic infection treatment
Parasitic infections
Possible alternative treatment for parasitic infections
Possible parasite protease inhibition
Potential new drug development
Potential treatment of parasitic infections
Protozoa treatment
Reconstitution of cell immunity
Reconstructed cell immunity
Reduce HIV viral load
Reduce opportunistic infections
Reduced Cryptosporidiosis
Reduced HIV infections
Reduced HIV viral load
Reduced Isosporiasis
Reduced Leishmania
Reduced OPI
Reduced OPI incidence
Reduced OPI risk
Reduced OPIs
Reduced TE
Reduced TE incidence
Reduced TE risk
Reduced cryptosporidiosis
Reduced isosporiasis
Reduced opportunistic infections
Reduced opportunistic parasite infections
Reduced toxoplasmic encephalitis
Reduced toxoplasmosis
Reduced viral load
Reduced visceral leishmaniasis
Reduces HIV viral load
Reduces OPIs
Reduction of OPIs
Reduction of opportunistic infections
Ritonavir and nelfinavir inhibit T. gondii
Stronger cell immunity
Suppressed HIV viral load
Suppression of HIV viral load
TE reduction
Toxoplasmic encephalitis treatment
Treatment for parasitic infections
Treats HIV
Treats opportunistic infections
Treats parasitic infections
Visceral leishmaniasis incidence decrease
Visceral leishmaniasis reduction
chronic diarrhoea improvement
cryptosporidiosis risk reduction
death risk reduction for cryptosporidiosis
isosporiasis relative hazard reduction
opportunistic infection reduction
potential for alternative parasitic treatment
reduced opportunistic infections
toxoplasmic encephalitis reduction
visceral leishmaniasis incidence decrease

Language : Italian


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Author: PrietoM J, BacigalupeD, PardiniO, AmalvyJ I, VenturiniC, MorillaM J, RomeroE L


Language : English


Language : English


Language : English


Language : English


Author: Sarzi-PuttiniPiercarlo, AtzeniFabiola, CapsoniFranco, LubranoEnnio, DoriaAndrea


Language : English


Language : English


Language : English


Language : English


Language : English


Language : Czech


Language : English


Language : English


This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.